Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality

British Journal of Haematology

Volumn 178, Issue 2, 2017, Pages 319-326

  Brunson, Ann ^a   Lei, Amy ^a   Rosenberg, Aaron S ^a   White, Richard H ^a   Keegan, Theresa ^a   Wun, Ted ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

deep vein thrombosis; pulmonary embolism; sickle cell disease; thrombosis; venous thromboembolism

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE REGISTRY; DISEASE SEVERITY; ETHNICITY; FEMALE; GENOTYPE; HISPANIC; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ICD-9-CM; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PACIFIC ISLANDER; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; RACE DIFFERENCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; VENOUS THROMBOEMBOLISM; ADOLESCENT; AGED; CALIFORNIA; CHILD; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; CALIFORNIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 85017094304     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14655     Document Type: Article

References (23)

1. Austin, H., Key, N.S., Benson, J.M., Lally, C., Dowling, N.F., Whitsett, C. & Hooper, W.C. (2007) Sickle cell trait and the risk of venous thromboembolism among blacks. Blood, 110, 908–912.
2. Bhan, N., Kawachi, I., Glymour, M.M. & Subramanian, S.V. (2015) Time Trends in Racial and Ethnic Disparities in Asthma Prevalence in the United States From the Behavioral Risk Factor Surveillance System (BRFSS) Study (1999–2011). American Journal of Public Health, 105, 1269–1275.
3. Boechat Tde, O., do Nascimento, E.M., Lobo, C.L. & Ballas, S.K. (2015) Deep venous thrombosis in children with sickle cell disease. Pediatric Blood & Cancer, 62, 838–841.
4. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. New England Journal of Medicine, 332, 1317–1322.
5. Fang, M.C., Go, A.S., Chang, Y., Borowsky, L.H., Pomernacki, N.K., Udaltsova, N. & Singer, D.E. (2011) A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. Journal of the American College of Cardiology, 58, 395–401.
6. Hassell, K.L. (2010) Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine, 38, S512–S521.
7. Heit, J.A. (2006) The epidemiology of venous thromboembolism in the community: implications for prevention and management. Journal of Thrombosis and Thrombolysis, 21, 23–29.
8. Heit, J.A. (2015) Epidemiology of venous thromboembolism. Nature Reviews Cardiology, 12, 464–474.
9. Kearon, C., Spencer, F.A., O'Keeffe, D., Parpia, S., Schulman, S., Baglin, T., Stevens, S.M., Kaatz, S., Bauer, K.A., Douketis, J.D., Lentz, S.R., Kessler, C.M., Moll, S., Connors, J.M., Ginsberg, J.S., Spadafora, L. & Julian, J.A. (2015) D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Annals of Internal Medicine, 162, 27–34.
10. Kearon, C., Ageno, W., Cannegieter, S.C., Cosmi, B., Geersing, G.J. & Kyrle, P.A. (2016a) Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. Journal of Thrombosis and Haemostasis, 14, 1480–1483.
11. Kearon, C., Akl, E.A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C.S., Morris, T.A., Sood, N., Stevens, S.M., Vintch, J.R., Wells, P., Woller, S.C. & Moores, L. (2016b) Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest, 149, 315–352.
12. Majoor, C.J., Kamphuisen, P.W., Zwinderman, A.H., Ten Brinke, A., Amelink, M., Rijssenbeek-Nouwens, L., Sterk, P.J., Buller, H.R. & Bel, E.H. (2013) Risk of deep vein thrombosis and pulmonary embolism in asthma. European Respiratory Journal, 42, 655–661.
13. Naik, R.P., Streiff, M.B., Haywood, Jr, C., Nelson, J.A. & Lanzkron, S. (2013) Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. American Journal of Medicine, 126, 443–449.
14. Naik, R.P., Streiff, M.B., Haywood, Jr, C., Segal, J.B. & Lanzkron, S. (2014) Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. Journal of Thrombosis and Haemostasis, 12, 2010–2016.
15. National Center for Health Statistics. (2014) ICD-9-CM: International Classification of Diseases, 9th Revision, Clinical Modification, 6th ed. Available at: https://www.cdc.gov/nchs/icd/icd9cm.htm
16. Novelli, E.M., Huynh, C., Gladwin, M.T., Moore, C.G. & Ragni, M.V. (2012) Pulmonary embolism in sickle cell disease: a case-control study. Journal of Thrombosis and Haemostasis, 10, 760–766.
17. Paulukonis, S.T., Harris, W.T., Coates, T.D., Neumayr, L., Treadwell, M., Vichinsky, E. & Feuchtbaum, L.B. (2014) Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatric Blood & Cancer, 61, 2271–2276.
18. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease. Rates and risk factors. New England Journal of Medicine, 325, 11–16.
19. Singer, D.E., Chang, Y., Fang, M.C., Borowsky, L.H., Pomernacki, N.K., Udaltsova, N. & Go, A.S. (2009) The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Annals of Internal Medicine, 151, 297–305.
20. Stein, P.D., Beemath, A., Meyers, F.A., Skaf, E. & Olson, R.E. (2006) Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. American Journal of Medicine, 119, e897–811.
21. White, R.H. (2003) The epidemiology of venous thromboembolism. Circulation, 107, I4–I8.
22. White, R.H., Garcia, M., Sadeghi, B., Tancredi, D.J., Zrelak, P., Cuny, J., Sama, P., Gammon, H., Schmaltz, S. & Romano, P.S. (2010) Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thrombosis Research, 126, 61–67.
23. Yu, T.T., Nelson, J., Streiff, M.B., Lanzkron, S. & Naik, R.P. (2016) Risk factors for venous thromboembolism in adults with hemoglobin SC or Sbeta(+) thalassemia genotypes. Thrombosis Research, 141, 35–38.